Skip to main content

Table 4 Grading of recommendation assessment, development, and evaluation

From: Predictors of adherence to prescribed exercise programs for older adults with medical or surgical indications for exercise: a systematic review

Predictors

Participants

Studies

+

0

−

Phase

Limitations

Inconsistency

Indirectness

Imprecision

Publication bias

↑ effect size

Dose effect

Quality

Effect

Demographic

 Age (older)

3591

10

2

5

3

2

✓

X

✓

✓

✓

∅

∅

M

~

 Sex (male)

2487

6

 

6

 

2

✓

✓

✓

✓

✓

∅

∅

H

~

 Employed

936

3

1

1

1

2

✓

X

✓

✓

X

∅

∅

L

~

 More education

1300

3

1

2

 

2

✓

X

✓

X

X

∅

∅

VL

~

 Living alone

210

2

 

2

 

2

✓

X

✓

✓

X

∅

∅

L

~

 Lower SES

842

2

  

2

2

✓

✓

✓

X

X

∅

∅

L

↓

Psychological

 Anxiety

1727

4

1

 

3

2

✓

X

✓

✓

X

∅

∅

L

~

 Depression

3775

7

 

2

5

2

✓

✓

✓

✓

✓

∅

Δ

H

↓

 Higher self-efficacy

313

3

3

  

2

✓

✓

✓

X

X

∅

Δ

M

↑

 Higher control

226

2

 

2

 

2

✓

✓

✓

X

X

∅

∅

L

~

 Good mental health

884

2

2

  

2

✓

✓

✓

✓

X

∅

∅

M

↑

Comorbidities

 High BMI

1848

3

 

3

 

2

✓

✓

✓

✓

X

∅

∅

M

~

 Smoker

1446

5

1

2

2

2

✓

X

✓

✓

X

∅

∅

L

~

 High cholesterol

158

3

1

2

 

2

✓

X

✓

X

X

∅

∅

VL

~

 Hypertension

128

2

 

2

 

2

✓

✓

✓

X

X

∅

∅

L

~

 Higher CCI

1268

2

 

2

 

2

✓

✓

✓

✓

X

∅

∅

M

~

Condition severity

 Better respiratory function

878

2

1

1

 

2

✓

X

✓

✓

X

∅

∅

L

~

 Higher FEV1

1658

2

1

1

 

2

✓

X

✓

✓

X

∅

∅

L

~

Program

 Farther distance

1444

2

  

2

2

✓

✓

✓

✓

X

∅

∅

M

↓

 Continuous exercise (vs intermittent)

75

2a

1

 

1

2

✓

X

✓

✓

X

∅

∅

M

~

Other

 Exercise history

160

2

1

1

 

2

✓

X

✓

X

X

∅

∅

VL

~

  1. + = number of studies with a significant positive effect; 0 = number of studies with no significant effect; − = number of studies with a significant negative effect; ✓ = no serious limitations; arandomized controlled trials; X serious limitations, Δ= present, ∅ not present, M moderate, H high, L low, VL very low